Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix.
- 1 January 1984
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 32 (1) , 284-290
- https://doi.org/10.1248/cpb.32.284
Abstract
The details of the isolation and antitumor activity of cyclic hexapeptides (RA-VII, RA-V, RA-IV and RA-III) isolated from Rubia cordifolia are reported. Studies on a spectrum of experimental tumors in mice revealed that the peptides exhibited significant activity against leukemias and ascites tumors, P-388, L1210, B-16 melanoma and solid tumors, colon 38, Lewis lung carcinoma and Ehrlich carcinoma. RA-V had an especially potent effect on MM2 mammary carcinoma in mice. The effective dose range of RA-IV against P-388 leukemia was different from those of the other cyclic hexapeptides.This publication has 5 references indexed in Scilit:
- In vivo Anti-Cancer Activity of RC-18Chemotherapy, 1982
- INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA1978
- EFFECTS OF BOUVARDIN (NSC 259968), A CYCLIC HEXAPEPTIDE FROM BOUVARDIA-TERNIFOLIA, ON PROGRESSION CAPACITY OF CULTURED CHINESE-HAMSTER CELLS1978
- Bouvardin and deoxybouvardin, antitumor cyclic hexapeptides from Bouvardia ternifolia (Rubiaceae)Journal of the American Chemical Society, 1977
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949